Study to Evaluate the Use of Resources and the Costs Associated With Carcinoid Syndrome (CS) in Patients With NETs in Spain

CompletedOBSERVATIONAL
Enrollment

142

Participants

Timeline

Start Date

July 21, 2017

Primary Completion Date

April 30, 2018

Study Completion Date

April 30, 2018

Conditions
Neuroendocrine Tumors
Interventions
OTHER

Data collection

The study consists of a single visit in which socio-demographic and clinical variables will be collected from the medical record or directly from the patient. In addition, the physician will provide information on the clinical status of the disease and the patient will fill in the questionnaire.

Trial Locations (28)

11009

Hospital Puerta del Mar, Cadiz

13005

Hospital General Univ. de Ciudad Real, Ciudad Real

19001

Hospital Univ. de Guadalajara, Guadalajara

20014

Hospital Univ. Donostia, Donostia / San Sebastian

28006

Hospital Univ. La Princesa, Madrid

28034

Hospital Univ. Ramón y Cajal, Madrid

28040

Hospital Clínico de San Carlos, Madrid

28041

Hospital 12 de Octubre, Madrid

28046

Hospital Univ. la Paz, Madrid

28807

Hospital Gregorio Marañón, Madrid

28911

Hospital Univ. Severo Ochoa, Leganés

29010

Hospital Virgen de la Victoria, Málaga

30008

Hospital Morales Meseguer, Murcia

33011

Hospital Univ. Central de Asturias, Oviedo

36071

Hospital Montecelo, Pontevedra

36214

Hospital do Meixoeiro, Vigo

37007

Hospital Clín. Univ. de Salamanca, Salamanca

41013

Hospital Virgen del Rocío, Seville

45004

Hospital Virgen de la Salud, Toledo

46017

Hospital Doctor Peset, Valencia

46026

Hospital la Fe de Valencia, Valencia

50009

Hospital Clínico Univ. Lozano Blesa, Zaragoza

Hospital Univ. Miguel Servet, Zaragoza

03203

Hospital General Univ. de Elche, Alicante

08916

ICO Badalona, Badalona

08036

Hospital Clínico y Provincial de Barcelona, Barcelona

08907

Hospital de Bellvitge, Barcelona

07120

Hospital Univ. Son Espases, Palma de Mallorca

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Ipsen

INDUSTRY